MedTrace Logo

The Effects of Coenzyme A on Serum Lipids in Patients With Hyperlipidemia

NCT01645046 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 294

Last updated 2012-07-19

No results posted yet for this study

Summary

The purpose of this study is to evaluate the lipid lowering effects and clinical safety of a natural hypolipidemic compound, coenzyme A （CoA） capsule in Chinese patients with moderate dyslipidemia.

Conditions

  • Hyperlipoproteinemia

Interventions

DRUG

Coenzyme A

Coenzyme A 200mg per day.

DRUG

Coenzyme A

Coenzyme A 400mg per day.

DRUG

Placebo

Capsule without coenzyme A.

Sponsors & Collaborators

  • Zhejiang University

    lead OTHER

Principal Investigators

  • Junzhu Chen, MD · Zhejiang University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2009-06-30
Completion
2009-08-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01645046 on ClinicalTrials.gov